Review
Published on 25 May 2021
Immunotherapy in Treating EGFR-Mutant Lung Cancer: Current Challenges and New Strategies
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.635007
- 45,940 views
- 115 citations
- Frontiers in Oncology
- Thoracic Oncology
- Articles
Type at least 3 characters
1,750 articles
Systematic Review
Published on 24 May 2021
Current Evidence of the Efficacy and Safety of Neoadjuvant EGFR-TKIs for Patients With Non-small Cell Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.608608
- 3,621 views
- 7 citations
Original Research
Published on 24 May 2021
Molecular Identification and Genetic Characterization of Early-Stage Multiple Primary Lung Cancer by Large-Panel Next-Generation Sequencing Analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.653988
- 5,951 views
- 26 citations
Original Research
Published on 24 May 2021
Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive Markers
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.674731
- 5,543 views
- 16 citations
Original Research
Published on 24 May 2021
Development and Validation of a Combined Model for Preoperative Prediction of Lymph Node Metastasis in Peripheral Lung Adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.675877
- 3,846 views
- 12 citations
Original Research
Published on 21 May 2021
High Expression of ACE2 and TMPRSS2 at the Resection Margin Makes Lung Cancer Survivors Susceptible to SARS-CoV-2 With Unfavorable Prognosis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.644575
- 4,601 views
- 19 citations
Mini Review
Published on 21 May 2021
Beyond Conventional: The New Horizon of Targeted Therapy for the Treatment of Advanced Non Small Cell Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.632256
- 6,240 views
- 11 citations
Original Research
Published on 20 May 2021
Methylation Regulation of TLR3 on Immune Parameters in Lung Adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.620200
- 2,869 views
- 6 citations
Original Research
Published on 18 May 2021
The Value of PETRA in Pulmonary Nodules of <3 cm Among Patients With Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.649625
- 3,143 views
- 3 citations
Original Research
Published on 17 May 2021
Surgery Plus Chemotherapy Versus Surgery Alone for Limited-Stage Small-Cell Lung Cancer: A Population-Based Survival Outcome Analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.676598
- 5,172 views
- 6 citations
Original Research
Published on 14 May 2021
Evaluation of Cell Surface Vimentin Positive Circulating Tumor Cells as a Diagnostic Biomarker for Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.672687
- 6,260 views
- 29 citations
Editorial
Published on 14 May 2021
Editorial: Emerging Biomarkers for NSCLC: Recent Advances in Diagnosis and Therapy
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.694578
- 3,239 views
- 7 citations
Original Research
Published on 14 May 2021
Blood Tumor Mutational Burden as a Predictive Biomarker in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.640761
- 4,181 views
- 10 citations
Original Research
Published on 13 May 2021
Phenotypic Plasticity Conferred by the Metastatic Microenvironment of the Brain Strengthens the Intracranial Tumorigenicity of Lung Tumor Cells
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.637911
- 2,952 views
- 5 citations
Original Research
Published on 13 May 2021
Age-Associated Changes in Adverse Events Arising From Anti-PD-(L)1 Therapy
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.619385
- 4,566 views
- 24 citations
Systematic Review
Published on 11 May 2021
Treatment-Related Serious Adverse Events of Immune Checkpoint Inhibitors in Clinical Trials: A Systematic Review
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.621639
- 6,179 views
- 17 citations